BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 5557667)

  • 1. Urinary fibrin split products in human renal disease.
    Stiehm ER; Kuplic LS; Uehling DT
    J Lab Clin Med; 1971 May; 77(5):843-52. PubMed ID: 5557667
    [No Abstract]   [Full Text] [Related]  

  • 2. Urinary fibrin split products in lupus nephritis.
    Zizic TM; Cwazka WF; Young NS; Stevens MB
    J Rheumatol; 1976 Mar; 3(1):43-9. PubMed ID: 775087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrin-fibrinogen degradation products in children with renal disease.
    Ambrus JL; Baliah T; Ambrus CM; Mink IB; Murphy GP
    N Y State J Med; 1974 Jul; 74(8):1396-402. PubMed ID: 4277485
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical morphological characteristics of intravascular coagulation in glomerulonephritis].
    Varshavskiĭ VA; Kupriianova LA; Kaliev RR; Poliantseva LR; Nikolaev AIu
    Arkh Patol; 1980; 42(2):12-8. PubMed ID: 6444806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance of urinary fibrin/fibrinogen degradation products (FDP) measured by highly sensitive ELISA method in various renal diseases].
    Shibata T; Sumie A; Ishii T; Tomo T; Magari Y; Sato J; Yasumori R; Nasu M
    Nihon Jinzo Gakkai Shi; 1993 Jun; 35(6):687-94. PubMed ID: 8377281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical significance of lymphocyturia in lupous nephritis].
    Samoĭlova SI
    Ter Arkh; 1973 May; 45(5):55-9. PubMed ID: 4768375
    [No Abstract]   [Full Text] [Related]  

  • 7. Fibrin-fibrinogen degradation products in children with renal disease.
    Uttley WS; Maxwell H; Cash JD
    Arch Dis Child; 1974 Feb; 49(2):137-42. PubMed ID: 4817446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fibrin (ogen) Split products of nephropathies].
    Anger H
    Urologe A; 1975 Jan; 14(1):20-4. PubMed ID: 234643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary fibrin split products in lupus nephritis. Correlation with other parameters of renal disease.
    Marchesi SL; Aptekar RG; Steinberg AD; Gralnick HR; Decker JL
    Arthritis Rheum; 1974; 17(2):158-64. PubMed ID: 4592571
    [No Abstract]   [Full Text] [Related]  

  • 10. Fragments of urinary fibrin/fibrinogen degradation products and cross-linked fibrin degradation products in various renal diseases.
    Taira K; Matsunaga T; Kawahara S; Sakamoto S; Kamitsuji H
    Thromb Res; 1989 Feb; 53(4):367-77. PubMed ID: 2929008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical importance of determining the fibrin breakdown products in certain kidney diseases].
    Belitskaia GA; Ena IaM; Varetskaia TV; Tsynkalovskaia SN; Tsariuk LA
    Vrach Delo; 1975 Mar; (3):105-9. PubMed ID: 1121813
    [No Abstract]   [Full Text] [Related]  

  • 12. Split products of fibrin in human renal disease.
    Stiehm ER; Trygstad CW
    Am J Med; 1969 May; 46(5):774-86. PubMed ID: 4182522
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical significance of urinary fibrin/fibrinogen degradation products in renal disease. Second report: Urinary fibrin/fibrinogen degradation products in nephrotic syndrome. (author' transl)].
    Miyamura S
    Nihon Jinzo Gakkai Shi; 1978 Apr; 20(4):315-26. PubMed ID: 671855
    [No Abstract]   [Full Text] [Related]  

  • 14. Urinary FDP in children with renal disease.
    Uttley W
    Arch Dis Child; 1973 Apr; 48(4):326. PubMed ID: 4705943
    [No Abstract]   [Full Text] [Related]  

  • 15. Histuria and fibrinuria in cases of systemic lupus erythematosus.
    Antoine B; Ward PD
    Clin Exp Immunol; 1970 Jan; 6(1):153-9. PubMed ID: 4984587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies on fibrinolytic therapy in children with various renal diseases with special reference to changes of urinary FDP x D-dimer fragments].
    Kamitsuji H; Iida Y; Omura R; Taira K; Tsukada S; Kusumoto K; Okamoto Y
    Nihon Jinzo Gakkai Shi; 1982 Nov; 24(11):1251-9. PubMed ID: 7166891
    [No Abstract]   [Full Text] [Related]  

  • 17. [Lupus nephropathy. Hematic, tissue and urinary signs of coagulation involvement].
    Stratta P; Canavese C; Dogliani M; Ragni R; Coppo R; Messina M; Rotunno M; Vercellone A
    Minerva Nefrol; 1981; 28(3):215-20. PubMed ID: 7329597
    [No Abstract]   [Full Text] [Related]  

  • 18. Thiamphenicol excretion in subjects with renal insufficiency.
    Azzollini F; Gazzaniga A; Lodola E
    Int Z Klin Pharmakol Ther Toxikol; 1970 Oct; 4(4):303-8. PubMed ID: 5494879
    [No Abstract]   [Full Text] [Related]  

  • 19. Thiamphenicol excretion in subjects with renal insufficiency.
    Azzollini F; Gazzaniga A; Lodola E
    Int Z Klin Pharmakol Ther Toxikol; 1970 Oct; 3(4):303-8. PubMed ID: 5481994
    [No Abstract]   [Full Text] [Related]  

  • 20. [Origin of urinary FDP in children with renal diseases].
    Yoshioka K; Iseki T; Ikeda H; Akano N; Uraoka Y; Miyata H; Maki S
    Nihon Jinzo Gakkai Shi; 1982 Mar; 24(3):285-93. PubMed ID: 7120693
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.